| pubmed-article:8320743 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8320743 | lifeskim:mentions | umls-concept:C0600688 | lld:lifeskim |
| pubmed-article:8320743 | lifeskim:mentions | umls-concept:C1511726 | lld:lifeskim |
| pubmed-article:8320743 | lifeskim:mentions | umls-concept:C2347947 | lld:lifeskim |
| pubmed-article:8320743 | lifeskim:mentions | umls-concept:C0175659 | lld:lifeskim |
| pubmed-article:8320743 | pubmed:issue | 14 | lld:pubmed |
| pubmed-article:8320743 | pubmed:dateCreated | 1993-8-5 | lld:pubmed |
| pubmed-article:8320743 | pubmed:abstractText | The toxicity of a given cancer therapy is an important end point in clinical trials examining the potential costs and benefits of that therapy. Treatment-related toxicity is conventionally measured with one of several toxicity criteria grading scales, even though the reliability and validity of these scales have not been established. | lld:pubmed |
| pubmed-article:8320743 | pubmed:language | eng | lld:pubmed |
| pubmed-article:8320743 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8320743 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:8320743 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8320743 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:8320743 | pubmed:issn | 0027-8874 | lld:pubmed |
| pubmed-article:8320743 | pubmed:author | pubmed-author:PaterJ LJL | lld:pubmed |
| pubmed-article:8320743 | pubmed:author | pubmed-author:ZehEE | lld:pubmed |
| pubmed-article:8320743 | pubmed:author | pubmed-author:BrundageM DMD | lld:pubmed |
| pubmed-article:8320743 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8320743 | pubmed:day | 21 | lld:pubmed |
| pubmed-article:8320743 | pubmed:volume | 85 | lld:pubmed |
| pubmed-article:8320743 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8320743 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:8320743 | pubmed:pagination | 1138-48 | lld:pubmed |
| pubmed-article:8320743 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:8320743 | pubmed:meshHeading | pubmed-meshheading:8320743-... | lld:pubmed |
| pubmed-article:8320743 | pubmed:meshHeading | pubmed-meshheading:8320743-... | lld:pubmed |
| pubmed-article:8320743 | pubmed:meshHeading | pubmed-meshheading:8320743-... | lld:pubmed |
| pubmed-article:8320743 | pubmed:meshHeading | pubmed-meshheading:8320743-... | lld:pubmed |
| pubmed-article:8320743 | pubmed:meshHeading | pubmed-meshheading:8320743-... | lld:pubmed |
| pubmed-article:8320743 | pubmed:meshHeading | pubmed-meshheading:8320743-... | lld:pubmed |
| pubmed-article:8320743 | pubmed:meshHeading | pubmed-meshheading:8320743-... | lld:pubmed |
| pubmed-article:8320743 | pubmed:meshHeading | pubmed-meshheading:8320743-... | lld:pubmed |
| pubmed-article:8320743 | pubmed:meshHeading | pubmed-meshheading:8320743-... | lld:pubmed |
| pubmed-article:8320743 | pubmed:meshHeading | pubmed-meshheading:8320743-... | lld:pubmed |
| pubmed-article:8320743 | pubmed:year | 1993 | lld:pubmed |
| pubmed-article:8320743 | pubmed:articleTitle | Assessing the reliability of two toxicity scales: implications for interpreting toxicity data. | lld:pubmed |
| pubmed-article:8320743 | pubmed:affiliation | Department of Community Health and Epidemiology, Queen's University, Kingston, Ontario, Canada. | lld:pubmed |
| pubmed-article:8320743 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:8320743 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8320743 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8320743 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8320743 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8320743 | lld:pubmed |
